4-Chlorokynurenine
A chemical compound used in research
4-Chlorokynurenine is a chemical compound that has been studied for its potential effects on the nervous system. It is a derivative of kynurenine, an intermediate in the tryptophan metabolism pathway. 4-Chlorokynurenine is of interest in neuroscience research due to its role as a prodrug for 7-chlorokynurenic acid, a potent antagonist of the NMDA receptor.
Chemical Structure[edit]
4-Chlorokynurenine is structurally similar to kynurenine, with the addition of a chlorine atom at the 4-position of the aromatic ring. This modification alters its pharmacological properties, making it a subject of interest in the study of neurotransmitter systems.
Mechanism of Action[edit]
4-Chlorokynurenine is metabolized in the body to produce 7-chlorokynurenic acid, which acts as an antagonist at the glycine site of the NMDA receptor. The NMDA receptor is a type of glutamate receptor that plays a crucial role in synaptic plasticity and memory function. By inhibiting this receptor, 4-chlorokynurenine may modulate excitatory neurotransmission and has been investigated for its potential therapeutic effects in neurological disorders.
Research and Applications[edit]
Research into 4-chlorokynurenine has focused on its potential use in treating conditions such as depression, schizophrenia, and neurodegenerative diseases. Its ability to cross the blood-brain barrier and be converted into an active NMDA receptor antagonist makes it a promising candidate for further study.
Safety and Toxicology[edit]
As with many experimental compounds, the safety profile of 4-chlorokynurenine is not fully established. Studies are ongoing to determine its potential side effects and toxicological properties in both animal models and human subjects.
Related pages[edit]
Gallery[edit]
-
Chemical structure of 4-Chlorokynurenine -
Ball-and-stick model of 4-Chlorokynurenine -
Illustration of an activated NMDA receptor
-
4-Chlorokynurenine chemical structure
-
4-Chlorokynurenine ball and stick model
-
Activated NMDA receptor
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
